Rheumatoid Arthritis Clinical Trials in Houston

Showing 2081-2100 of 2,948 trials

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

NCT02307240

This is a Phase I, open-label, multi-center trial designed to evaluate the safety, tolerability and pharmacokinetics of CUDC-907 administered orally to subjects with advanced/relapsed solid tumors.

Triple-Negative Breast CancerHigh-grade Serous Ovarian CancerSolid Tumors+1 more

Curis, Inc.43 participantsStarted Nov 2014

San Francisco, California, United States • Sarasota, Florida, United States • Boston, Massachusetts, United States +1 more locations

UNKNOWN< 1 mile

Primary Mitral Regurgitation Repair

NCT04067635

This longitudinal cohort study evaluates the relationship of myocardial tissue markers characteristics assessed by cardiac MRI, with clinical measures of symptoms and functions in adults with primary mitral regurgitation. Participants are followed conservatively or may choose to undergo surgical repair at the discretion of their clinical team.

Mitral Valve InsufficiencyMitral Valve ProlapseChronic Mitral Disease+5 more

Eric Y. Yang, MD PhD116 participantsStarted May 2018

Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

NCT01447914

This phase II trial studies the side effects and how well tivantinib works in treating patients with relapsed, or relapsed and refractory multiple myeloma. Tivantinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

Refractory Multiple Myeloma

National Cancer Institute (NCI)16 participantsStarted Nov 2011

Houston, Texas, United States

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

Primary Mitral Regurgitation Repair

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

Rheumatoid Arthritis Trials in Other Cities

Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer

Pharmacogenetic Clinical Trial of Nepicastat for Post Traumatic Stress Disorder (PTSD)

BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity

Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery

A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

Radiation Therapy in Treating Young Patients With Gliomas

Multi-Institutional Registry for Prostate Cancer Radiosurgery

Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles

An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

Safety and Preliminary Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy

A Comparison of Web-Prolonged Exposure (Web-PE) and Present-Centered Therapy (PCT) for PTSD Among Active-Duty Military Personnel

Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation

Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation

A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis

Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children

Reevaluation Of Systemic Early Neuromuscular Blockade

Other Conditions in Houston